| 0.2 |
0.6 |
GO:0070948 |
regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
| 0.2 |
0.5 |
GO:0070237 |
positive regulation of activation-induced cell death of T cells(GO:0070237) |
| 0.2 |
0.5 |
GO:0002414 |
immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.2 |
0.5 |
GO:1903991 |
positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
| 0.1 |
0.4 |
GO:1904456 |
negative regulation of neuronal action potential(GO:1904456) |
| 0.1 |
0.4 |
GO:0019442 |
tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.1 |
0.4 |
GO:1902567 |
negative regulation of eosinophil activation(GO:1902567) |
| 0.1 |
0.4 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.1 |
0.3 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.1 |
0.4 |
GO:0021502 |
neural fold elevation formation(GO:0021502) |
| 0.1 |
0.7 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.1 |
0.3 |
GO:0098976 |
excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.1 |
0.2 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.1 |
0.3 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
| 0.1 |
0.3 |
GO:0099526 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.1 |
0.6 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
0.3 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 |
0.2 |
GO:0071799 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 |
0.5 |
GO:0007527 |
adult somatic muscle development(GO:0007527) |
| 0.1 |
0.4 |
GO:0006742 |
NADP catabolic process(GO:0006742) |
| 0.1 |
0.4 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.1 |
0.6 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
0.1 |
GO:0051795 |
positive regulation of catagen(GO:0051795) |
| 0.1 |
0.5 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 |
0.2 |
GO:0021762 |
substantia nigra development(GO:0021762) |
| 0.1 |
0.2 |
GO:0048822 |
enucleate erythrocyte development(GO:0048822) positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 |
0.3 |
GO:1903003 |
positive regulation of protein deubiquitination(GO:1903003) |
| 0.1 |
0.5 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.2 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 |
0.2 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.1 |
0.2 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 |
0.3 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
0.2 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 0.1 |
0.2 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.2 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 |
0.2 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 |
0.4 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
0.2 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
2.5 |
GO:0050911 |
detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 |
0.0 |
GO:0072717 |
cellular response to actinomycin D(GO:0072717) |
| 0.0 |
0.2 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.0 |
0.6 |
GO:0003138 |
primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.0 |
0.1 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.0 |
0.3 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.0 |
0.2 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.0 |
0.1 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.0 |
0.2 |
GO:0061402 |
glycerol biosynthetic process(GO:0006114) positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
| 0.0 |
0.1 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.0 |
0.2 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.0 |
0.3 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.2 |
GO:0006203 |
dGTP catabolic process(GO:0006203) dATP catabolic process(GO:0046061) |
| 0.0 |
0.2 |
GO:0070295 |
glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
| 0.0 |
0.1 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.0 |
0.1 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.0 |
0.6 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 |
0.4 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.0 |
0.2 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.0 |
0.4 |
GO:0002913 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.0 |
0.2 |
GO:0035660 |
MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
| 0.0 |
0.1 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.0 |
0.5 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.0 |
0.1 |
GO:0039521 |
lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) amino acid homeostasis(GO:0080144) negative regulation of sphingolipid biosynthesis involved in cellular sphingolipid homeostasis(GO:0090157) |
| 0.0 |
0.1 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.0 |
0.1 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.0 |
0.3 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 |
0.1 |
GO:0071317 |
cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.0 |
0.3 |
GO:0072619 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.2 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.0 |
0.3 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.0 |
0.2 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.0 |
0.5 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 |
0.1 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.0 |
0.2 |
GO:1901529 |
positive regulation of anion channel activity(GO:1901529) |
| 0.0 |
0.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.0 |
0.8 |
GO:0097340 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.0 |
0.2 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.0 |
0.2 |
GO:0071350 |
interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
| 0.0 |
0.3 |
GO:0002138 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.0 |
0.1 |
GO:0046226 |
coumarin metabolic process(GO:0009804) coumarin catabolic process(GO:0046226) |
| 0.0 |
0.3 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.2 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.1 |
GO:1903904 |
negative regulation of establishment of T cell polarity(GO:1903904) |
| 0.0 |
0.2 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.0 |
0.1 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.0 |
0.1 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.0 |
0.2 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 |
0.0 |
GO:0060459 |
inhibition of neuroepithelial cell differentiation(GO:0002085) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
| 0.0 |
0.1 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.0 |
0.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.3 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.1 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 |
0.5 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.3 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.0 |
0.1 |
GO:1902748 |
positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.0 |
7.2 |
GO:0050907 |
detection of chemical stimulus involved in sensory perception(GO:0050907) |
| 0.0 |
0.2 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.0 |
0.3 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.0 |
0.2 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.1 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.0 |
0.3 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 |
0.1 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.0 |
24.0 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.1 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 |
0.1 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.0 |
0.1 |
GO:0033577 |
protein glycosylation in endoplasmic reticulum(GO:0033577) |
| 0.0 |
0.0 |
GO:1903564 |
regulation of protein localization to cilium(GO:1903564) |
| 0.0 |
0.4 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.6 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.2 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 |
0.1 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.0 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 |
2.8 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.2 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.0 |
0.1 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.0 |
0.2 |
GO:0098953 |
receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
| 0.0 |
0.2 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.0 |
0.1 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) |
| 0.0 |
0.4 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.2 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.0 |
0.3 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.1 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.0 |
0.3 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.0 |
0.1 |
GO:0010286 |
heat acclimation(GO:0010286) |
| 0.0 |
0.5 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
0.3 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.0 |
0.0 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.0 |
0.3 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.6 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.0 |
0.3 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.0 |
0.3 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.1 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.0 |
0.1 |
GO:0046149 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.0 |
0.2 |
GO:1902563 |
regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.0 |
0.2 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.1 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.0 |
0.1 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.2 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.2 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 |
0.2 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.0 |
0.2 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.0 |
0.1 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.0 |
0.0 |
GO:0007208 |
phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
| 0.0 |
2.0 |
GO:0007606 |
sensory perception of chemical stimulus(GO:0007606) |
| 0.0 |
0.1 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.0 |
0.0 |
GO:0045659 |
negative regulation of neutrophil differentiation(GO:0045659) |
| 0.0 |
0.0 |
GO:2001137 |
protein retention in Golgi apparatus(GO:0045053) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) positive regulation of endocytic recycling(GO:2001137) |
| 0.0 |
0.0 |
GO:1904444 |
regulation of establishment of Sertoli cell barrier(GO:1904444) |
| 0.0 |
0.0 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.0 |
0.1 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.0 |
0.1 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
